Literature DB >> 15161330

The management of hypertension in the overweight and obese patient: is weight reduction sufficient?

Stephan Jacob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15161330     DOI： 10.2165/00003495-200464110-00007

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  6 in total

1.  Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

Authors:  David E Kelley; George A Bray; F Xavier Pi-Sunyer; Samuel Klein; James Hill; John Miles; Priscilla Hollander
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

2.  Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

Authors:  P A Hollander; S C Elbein; I B Hirsch; D Kelley; J McGill; T Taylor; S R Weiss; S E Crockett; R A Kaplan; J Comstock; C P Lucas; P A Lodewick; W Canovatchel; J Chung; J Hauptman
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

Review 3.  The management of hypertension in the overweight and obese patient: is weight reduction sufficient?

Authors:  James D Douketis; Arya M Sharma
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Authors:  John M Miles; Lawrence Leiter; Priscilla Hollander; Thomas Wadden; James W Anderson; Michael Doyle; John Foreyt; Louis Aronne; Samuel Klein
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

5.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

Authors:  Jarl S Torgerson; Jonathan Hauptman; Mark N Boldrin; Lars Sjöström
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

6.  Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension.

Authors:  Arya M Sharma; Alain Golay
Journal:  J Hypertens       Date:  2002-09       Impact factor: 4.844
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.